Naveen K. Krishnegowda

598 total citations
20 papers, 496 citations indexed

About

Naveen K. Krishnegowda is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Naveen K. Krishnegowda has authored 20 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Genetics and 6 papers in Oncology. Recurrent topics in Naveen K. Krishnegowda's work include Mesenchymal stem cell research (4 papers), Estrogen and related hormone effects (4 papers) and Bone Tissue Engineering Materials (3 papers). Naveen K. Krishnegowda is often cited by papers focused on Mesenchymal stem cell research (4 papers), Estrogen and related hormone effects (4 papers) and Bone Tissue Engineering Materials (3 papers). Naveen K. Krishnegowda collaborates with scholars based in United States and India. Naveen K. Krishnegowda's co-authors include Morton S. Kahlenberg, Margarita Mikhailova, Dean A. Troyer, Roble Bedolla, Thomas J. Prihoda, P. Ghosh, Shazli N. Malik, Jeffrey I. Kreisberg, Joel Michalek and Rajeshwar R. Tekmal and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Naveen K. Krishnegowda

20 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naveen K. Krishnegowda United States 11 226 199 72 58 57 20 496
Weixi Shen China 14 181 0.8× 138 0.7× 33 0.5× 155 2.7× 21 0.4× 28 580
Meng Sun China 12 214 0.9× 175 0.9× 86 1.2× 121 2.1× 12 0.2× 43 590
Jen‐Tsun Lin Taiwan 16 306 1.4× 60 0.3× 48 0.7× 126 2.2× 82 1.4× 34 669
Yu-Chu Su Taiwan 15 297 1.3× 60 0.3× 50 0.7× 108 1.9× 13 0.2× 18 605
Jun Da China 14 255 1.1× 156 0.8× 186 2.6× 142 2.4× 14 0.2× 30 722
R Schneider-Stock Germany 13 290 1.3× 143 0.7× 97 1.3× 110 1.9× 19 0.3× 24 622
Yu Bai China 16 451 2.0× 159 0.8× 83 1.2× 228 3.9× 14 0.2× 49 848
Fengyun Dong China 17 235 1.0× 42 0.2× 33 0.5× 130 2.2× 33 0.6× 25 612
Jingjing Yao China 15 355 1.6× 111 0.6× 43 0.6× 83 1.4× 23 0.4× 49 628

Countries citing papers authored by Naveen K. Krishnegowda

Since Specialization
Citations

This map shows the geographic impact of Naveen K. Krishnegowda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naveen K. Krishnegowda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naveen K. Krishnegowda more than expected).

Fields of papers citing papers by Naveen K. Krishnegowda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naveen K. Krishnegowda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naveen K. Krishnegowda. The network helps show where Naveen K. Krishnegowda may publish in the future.

Co-authorship network of co-authors of Naveen K. Krishnegowda

This figure shows the co-authorship network connecting the top 25 collaborators of Naveen K. Krishnegowda. A scholar is included among the top collaborators of Naveen K. Krishnegowda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naveen K. Krishnegowda. Naveen K. Krishnegowda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ramasamy, Kumaraguruparan, et al.. (2017). Therapeutic Use of Estrogen Receptor β Agonists in Prevention and Treatment of Endocrine Therapy Resistant Breast Cancers: Observations From Preclinical Models. Progress in molecular biology and translational science. 151. 177–194. 9 indexed citations
3.
Nair, Hareesh B., et al.. (2016). Effects of Combination of Estradiol with Selective Progesterone Receptor Modulators (SPRMs) on Human Breast Cancer Cells In Vitro and In Vivo. PLoS ONE. 11(3). e0151182–e0151182. 3 indexed citations
4.
Kost, Edward R., Philip T. Valente, Naveen K. Krishnegowda, et al.. (2016). Clinical and Pathologic Features of Hispanic Endometrial Cancer Patients With Loss of Mismatch Repair Expression. International Journal of Gynecological Cancer. 26(6). 1129–1136. 5 indexed citations
5.
Knudtson, Jennifer F., Rajeshwar R. Tekmal, Peter Binkley, et al.. (2015). Impaired Development of Early Endometriotic Lesions in CD44 Knockout Mice. Reproductive Sciences. 23(1). 87–91. 14 indexed citations
6.
Cornejo, Agustin, Teja Guda, David E. Sahar, et al.. (2014). Differentiated Adipose-Derived Stem Cell Cocultures for Bone Regeneration in Polymer Scaffolds In Vivo. Journal of Craniofacial Surgery. 25(4). 1504–1509. 19 indexed citations
7.
Krishnegowda, Naveen K., et al.. (2014). Abstract 622: S-equol, an estrogen receptor β agonist, inhibits tumor growth and progression of breast cancer. Cancer Research. 74(19_Supplement). 622–622. 1 indexed citations
8.
Bhaskaran, Shylesh, Sathyaseelan S. Deepa, C. Sadasivan, et al.. (2013). Gossypin as a Novel Selective Dual Inhibitor of v-raf Murine Sarcoma Viral Oncogene Homolog B1 and Cyclin-Dependent Kinase 4 for Melanoma. Molecular Cancer Therapeutics. 12(4). 361–372. 21 indexed citations
9.
10.
Cornejo, Agustin, David E. Sahar, Stacy M. Stephenson, et al.. (2012). Effect of Adipose Tissue-Derived Osteogenic and Endothelial Cells on Bone Allograft Osteogenesis and Vascularization in Critical-Sized Calvarial Defects. Tissue Engineering Part A. 18(15-16). 1552–1561. 42 indexed citations
11.
Sahar, David E., John Walker, Howard T. Wang, et al.. (2012). Effect of Endothelial Differentiated Adipose-Derived Stem Cells on Vascularity and Osteogenesis in Poly(D,L-Lactide) Scaffolds In Vivo. Journal of Craniofacial Surgery. 23(3). 913–918. 17 indexed citations
12.
13.
Nair, Hareesh B., Nameer B. Kirma, Naveen K. Krishnegowda, et al.. (2011). Estrogen Receptor-beta Mediates the Protective Effects of Aromatase Induction in the MMTV-Her-2/neu x Aromatase Double Transgenic Mice. Hormones and Cancer. 3(1-2). 26–36. 6 indexed citations
14.
Krishnegowda, Naveen K., et al.. (2011). Novel Function of Transcription Factor Nrf2 as an Inhibitor of RON Tyrosine Kinase Receptor-mediated Cancer Cell Invasion. Journal of Biological Chemistry. 286(37). 32115–32122. 29 indexed citations
15.
Nair, Hareesh B., Naveen K. Krishnegowda, Binoj C. Nair, et al.. (2010). Abstract 4607: Novel role of PARP4 in hormone-dependent breast cancer progression and metastasis. Cancer Research. 70(8_Supplement). 4607–4607. 1 indexed citations
16.
Bingener, Juliane, Naveen K. Krishnegowda, & Joel Michalek. (2008). Immunologic parameters during NOTES compared with laparoscopy in a randomized blinded porcine trial. Surgical Endoscopy. 23(1). 178–181. 26 indexed citations
17.
Bedolla, Roble, Thomas J. Prihoda, Jeffrey I. Kreisberg, et al.. (2007). Determining Risk of Biochemical Recurrence in Prostate Cancer by Immunohistochemical Detection of PTEN Expression and Akt Activation. Clinical Cancer Research. 13(13). 3860–3867. 115 indexed citations
18.
Krishnegowda, Naveen K., et al.. (2007). Flavonoid, Silibinin, Inhibits Proliferation and Promotes Cell-Cycle Arrest of Human Colon Cancer. Journal of Surgical Research. 143(1). 58–65. 156 indexed citations
19.
Krishnegowda, Naveen K., et al.. (2007). 46. Journal of Surgical Research. 137(2). 169–170. 3 indexed citations
20.
Learn, Peter A., et al.. (2006). Compensatory Increases in Her-2/neu Activation in Response to EGFR Tyrosine Kinase Inhibition in Colon Cancer Cell Lines. Journal of Surgical Research. 136(2). 227–231. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weixi Shen Breakdown of academic impact, for papers by Meng Sun Breakdown of academic impact, for papers by Jen‐Tsun Lin Breakdown of academic impact, for papers by Yu-Chu Su Breakdown of academic impact, for papers by Jun Da Breakdown of academic impact, for papers by R Schneider-Stock Breakdown of academic impact, for papers by Yu Bai Breakdown of academic impact, for papers by Fengyun Dong Breakdown of academic impact, for papers by Jingjing Yao
Rankless by CCL
2026